Bio-Rad Laboratories(FRA) BUWA

Market Cap€8.91B

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€330.60

-0.66%

-2.20Today

Bio-Rad Laboratories Financials at a Glance

Market Cap

€8.91B

Revenue (TTM)

€2.22K

Net Income (TTM)

€194.91

EPS (TTM)

€7.23

P/E Ratio

46.09

Dividend

€0.00

Beta (Volatility)

0.00 (Low)

Dividend

€0.00

Beta (Volatility)

0.00 (Low)

Price

€330.60

Volume

Open

€330.60

Price

€330.60

Volume

Open

€330.60

Previous Close

€332.80

Daily Range

€330.60 - €330.60

52-Week Range

€204.60 - €334.00

Estimated Earnings Date

N/A

Dividend

€0.00

Beta (Volatility)

0.00 (Low)

Price

€330.60

Volume

Open

€330.60

Previous Close

€332.80

Daily Range

€330.60 - €330.60

52-Week Range

€204.60 - €334.00

Estimated Earnings Date

N/A

BUWA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

7,400

CEO

Norman D. Schwartz

Website

www.bio-rad.com

BUWA Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

3.16%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

2.17%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€8.91B

Shares Outstanding

26.74M

Volume

Avg. Volume

14.121

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Bio-Rad Laboratories Performance Analysis

Bio-Rad Laboratories annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 2,666,334,425	7.8%
2023	2023-12-31	EUR 2,470,838,449	-7.3%
2024	2024-12-31	EUR 2,372,674,431	-4.0%
2025	2025-12-31	EUR 2,288,898,165	-3.5%

Bio-Rad Laboratories annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR -115.88	N/A
2023	2023-12-31	EUR -20.18	-82.6%
2024	2024-12-31	EUR -60.43	199.4%
2025	2025-12-31	EUR 24.68	N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€559.90

+1.0%

Gross Profit

€297.41

+1.0%

Gross Margin

53.12%

+1.0%

Market Cap

€8.91B

N/A

Market Cap/Employee

€0.93

N/A

Employees

7,400

N/A

Net Income

€319.43

+1.1%

EBITDA

€105.96

+0.9%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€1.65K

+9.1%

Total Debt

€1.20K

+1.0%

Accounts Receivable

€386.43

+1.0%

Inventory

€682.76

+1.0%

Long Term Debt

€818.77

+0.7%

Short Term Debt

€379.87

+11.0%

Return on Assets

2.21%

+0.7%

Return on Invested Capital

-4.78%

N/A

Free Cash Flow

€57.78

+1.0%

Operating Cash Flow

€85.46

+0.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.92+0.00%

WETOWetour Robotics

WETOWetour Robotics$5.48-0.04%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$44.67+0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

INTCIntel

INTCIntel$89.51+0.00%

NOKNokia

NOKNokia$10.14-0.01%

NVDANvidia

NVDANvidia$220.78+0.01%

Questions About BUWA

What is the current price of Bio-Rad Laboratories?

Bio-Rad Laboratories is trading at €330.60 per share.

What is the 52-week range for Bio-Rad Laboratories?

Over the past 52 weeks, Bio-Rad Laboratories has traded between €204.60 and €334.00.

How much debt does Bio-Rad Laboratories have?

As of the most recent reporting period, Bio-Rad Laboratories reported total debt of €1.20B.

How much cash does Bio-Rad Laboratories have on hand?

Bio-Rad Laboratories reported €453.60M in cash and cash equivalents in its most recent financial results.

What is Bio-Rad Laboratories’s dividend yield?

Bio-Rad Laboratories does not currently have a dividend yield.

Bio-Rad Laboratories(FRA) BUWA

Bio-Rad Laboratories Financials at a Glance

BUWA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Bio-Rad Laboratories

BUWA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Bio-Rad Laboratories Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BUWA

What is the current price of Bio-Rad Laboratories?

What is the 52-week range for Bio-Rad Laboratories?

How much debt does Bio-Rad Laboratories have?

How much cash does Bio-Rad Laboratories have on hand?

What is Bio-Rad Laboratories’s dividend yield?

Premium Investing Services